Effects of Kinematic Biofeedback on Gait Quality in People With Stroke

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Walking disorder is the most common and concerning issue for individuals with stroke. Previous studies have often used improvements in walking speed and distance as reference indicators for the advancement of gait performance in individuals with stroke. However, for individuals with chronic stroke, considering gait symmetry and variability to enhance gait quality as the primary intervention target may be more crucial. According to a literature review, it can be inferred that the application of biofeedback to detect gait quality may be an effective approach to improve gait symmetry and variability in individuals with stroke. However, there is still insufficient research evidence on this issue. Therefore, this study aims to investigate the effects of a kinematic biofeedback device system, which detects hip joint angles, on gait quality in individuals with chronic stroke.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 80
Healthy Volunteers: f
View:

• First stroke

• Stroke onset time ≥ 6 months

• Functional Ambulation Category ≥3

• Passive range of motion of affected hip extension is at least 10 degrees

• Mini-Mental State Measurement score ≥ 24 points

Locations
Other Locations
Taiwan
Department of Physical Therapy and Assistive Technology, National Yang Ming Chiao Tung University
RECRUITING
Taipei
Contact Information
Primary
Yea-Ru Yang, PhD
yryang@nycu.edu.tw
+886228267279
Time Frame
Start Date: 2024-10-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 40
Treatments
Experimental: Gait training with biofeedback group
The intervention is a single 60-minute session.
Active_comparator: Gait training without biofeedback group
The intervention is a single 60-minute session.
Related Therapeutic Areas
Sponsors
Leads: National Yang Ming Chiao Tung University

This content was sourced from clinicaltrials.gov